Biography
Dr. Purcell is a genetic epidemiologist whose work focuses on developing statistical and computational tools for the design of genetic studies, the detection of gene variants influencing complex human traits and the dissection of these effects in the larger context of other genetic and environmental factors. In particular, Dr. Purcell currently works on whole exome resequencing and whole genome association studies of bipolar disorder and schizophrenia, and the development of tools for whole genome and exome genetic studies. He directs the Center for Statistical Genetics at Mount Sinai School of Medicine, and is a Member of the Division of Psychiatric Genomics and the Institute for Genomics and Multiscale Biology.
Research
Dr. Purcell collaborates on a number of genetic studies ongoing in the IPM.Dr. Purcell is Principal Investigator on National Institutes of Health (NIH) - funded grants for whole - exome sequencing in schizophrenia and bipolar disorder, and for developing analytic tools for next-generation sequencing studies, in addition to being an Investigator on several other large-scale, collaborative genetic studies of neuropsychiatric disease. He is the Chair of Mount Sinai’s Genomics arm of the eMERGE II project.
Research Interests:
- Development of statistical genetic methodology and computational tools for large - scale genotyping and sequencing studies
- Neuropsychiatric genetics
- Characterizing the genetic architecture of common disease
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Purcell did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 3 Room Suite 3-31 Rm 3-66
1425 Madison Avenue
New York, NY 10029